Minocycline hydrochloride is named as a drug or biological intervention in 4 clinical trials in our China trial register, 4 of which are recruiting. Lead sponsors include Xiang Luo (2) and Beijing Tiantan Hospital (2). Registered phases: Phase 2/3 and Phase 3. Conditions studied include Acute Ischemic Stroke; Endovascular Thrombectomy; Vessel Occlusion.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07338175 | Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage (ClinicalTrials.gov ↗) Intracerebral Hemorrhage |
Phase 3 | Recruiting |
| NCT07526987 | Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis (ClinicalTrials.gov ↗) Ischaemic Stroke |
Phase 3 | Recruiting |
| NCT07594301 | Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP) (ClinicalTrials.gov ↗) Acute Ischemic Stroke, Endovascular Thrombectomy, Minocycline |
Phase 2/3 | Recruiting |
| NCT07594314 | Minocycline After Successful Endovascular Thrombectomy Recanalization in Acute Anterior Circulation Large Vessel Occlusion (ATTRACTION-MINOA) (ClinicalTrials.gov ↗) Acute Ischemic Stroke, Vessel Occlusion, Endovascular Thrombectomy |
Phase 2/3 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Acute Ischemic Stroke | 2 |
| Endovascular Thrombectomy | 2 |
| Vessel Occlusion | 1 |
| Anterior Circulation Brain Infarction | 1 |
| Intracerebral Hemorrhage | 1 |
| Minocycline | 1 |
| Posterior Circulation | 1 |
| Ischaemic Stroke | 1 |
| Lead sponsor | Trials |
|---|---|
| Xiang Luo | 2 |
| Beijing Tiantan Hospital | 2 |
| Register | Minocycline hydrochloride trials |
|---|---|
| Clinical trials in China | 4 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Minocycline hydrochloride works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Minocycline hydrochloride (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.